Abstract
Early diagnosis of lung cancer is critical, as most cases are already inoperable at the time of diagnosis, and thus bear a grave prognosis. With increasing knowledge of the genetic aspects of lung cancer, the field has also experienced an increasing number of potential markers that might serve in the detection of changes in the lung epithelium that predispose to cancer (reviewed in refs. 1–3). Of these, oncogene mutations were among the first genetic biomarkers to be studied extensively, since they fulfill many criteria that link their de novo appearance to the process of field cancerization (4). Oncogene mutations of the ras- and p53-type are found in chronic smokers and patients with preneoplastic and neoplastic lesions but almost never in normal lung (4). In animal models carcinogens present in tobacco smoke have been shown to induce typical G-T transversions that lead to missense mutations (5). Moreover it has been shown that smoking leads to particular types of mutations, many of which are concentrated in particular hot spots, thus making it plausible that the same spectrum also arises in man on continuous exposure to tobacco carcinogens.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sekido, Y., Fong, K. M., and Minna, J. D. (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta 1378, F21–F59.
Salgia, R. and Skarin, A. T. (1998) Molecular abnormalities in lung cancer. J. Clin. Oncol. 16, 1207–1217.
Sozzi, G. and Carney, D. (1998) Molecular biology of lung cancer. Curr. Opin. Pulm. Med. 4, 207–212.
Fong, K. M., Sekido, Y., and Minna J. D. (1999) Molecular pathogenesis of lung cancer. J. Thorac. Cardiovasc. Surg. 118, 1136–1152.
Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430–432.
Rodenhuis, S. and Slebos, R. J. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 52, 2665s–2669s.
Husgafvel-Pursiainen, K., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., et al. (1993) K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer 53, 250–256.
Li, S., Rosell, R., Urban, A., Font, A., Ariza, A., Armengol, P., et al. (1994) K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma. Lung Cancer 11, 19–27.
Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M., and Sidransky, D. (1994) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54, 1634–1637.
Mills, N. E., Fishman, C. L., Rom, W. N., Dubin, N., and Jacobson, D. R. (1995) Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444–1447.
Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I,. Minna, J. D., and Gazdar, A. F. (1991) Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene 6, 1353–1362.
Rodenhuis, S., Slebos, R. J., Boot, A. J., Evers, S. G., Mooi, W. J., Wagenaar, S. S., et al. (1988) Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 48, 5738–5741.
Rodenhuis, S. and Slebos, R. J. (1990) The ras oncogenes in human lung cancer. Am. Rev. Respir. Dis. 142, 27–30.
Chiba, I., Takahashi, T., Nau, M. M., D’Amico, D., Curiel, D. T., Mitsudomi, T., et al. (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5, 1603–1610.
Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., et al. (1993) p53 mutations and histological type of invasive breast carcinoma. Cancer Res. 53, 4665–4669.
Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. (1991) The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6, 1775–1778.
Top, B., Mooi, W. J., Klaver, S. G., Boerrigter, L., Wisman, P., Elbers, H. R., et al. (1995) Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer. Int. J. Cancer 64, 83–91.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855–4878.
Sugio, K., Kishimoto, Y., Virmani, A. K., Hung, J. Y., and Gazdar A. F. (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res. 54, 5811–5815.
Fontanini, G., Vignati, S., Bigini, D., Merlo, G. R., Ribecchini, A., Angeletti, C. A., et al. (1994) Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J. Pathol. 174, 23–31.
Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., et al. (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res. 52, 6079–6082.
Walker, C., Robertson, L. J., Myskow, M. W., Pendleton, N., and Dixon, G. R. (1994) p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer 70, 297–303.
Orita, M., Suzuki, T., and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879.
Takahashi, N., Hiyama, K., Kodaira, M., and Satoh, C. (1990) An improved method for the detection of genetic variations in DNA with denaturing gradient gel electrophoresis. Mutat. Res. 234, 61–70.
Anwar, K., Nakakuki, K., Shiraishi, T., Naiki, H., Yatani, R., and Inuzuka, M. (1992) Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res. 52, 5991–5996.
Yashiro, T., Fulton, N., Hara, H., Yasuda, K., Montag, A., Yashiro, N., et al. (1993) Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114, 758–763.
Lepage, V., Ivanova, R., Loste, M.N., Mallet, C., Douay, C., Naoumova, E., and Charron, D. (1995) Determination of DQB1 alleles using PCR amplification and allele-specific primers. Eur. J. Immunogenet. 22, 413–422.
Ørum, H., Nielsen, P. E., Egholm, M., Berg, R. H., Buchardt, O., and Stanley, C. (1993) Single base pair mutation analysis by PNA directed PCR clamping. Nucleic Acids Res. 21, 5332–5336.
Thiede, C., Bayerdorffer, E., Blasczyk, R., Wittig, B., and Neubauer, A. (1996) Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Res. 24, 983–984.
Behn, M., Thiede, C., Neubauer, A., Pankow, W., and Schuermann, M. (2000) Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated ‘enriched PCR’ protocol. J. Pathol. 190, 69–75.
Rhodes, C. H., Honsinger, C., Porter, D.M., and Sorenson, G. D. (1997) Analysis of the allele-specific PCR method for the detection of neoplastic disease. Diagn. Mol. Pathol. 6, 49–57.
Kahn, S. M., Jiang, W., Culbertson, T. A., Weistein, I. B., Williams, G. M., Tomita, N., and Ronai, Z. (1991) Rapid and sensitive nonradioactive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene 6, 1079–1083.
Levi, S., Urbano-Ispizua, A., Gill, R., Thomas, D. M., Gilbertson, J., Foster, C., and Marshall, C. J. (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res. 51, 3497–3502.
Jacobson, D. R. and Mills, N. E. (1994) A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene 9, 553–563.
Sugio, K., Kishimoto, Y., Virmani, A. K., Hung, J. Y., and Gazdar, A. F. (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res. 54, 5811–5815.
Mills, N. E., Fishman, C. L., Scholes, J., Anderson, S. E., Rom, W. N., and Jacobson, D. R. (1995) Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst. 87, 1056–1060.
Behn, M., Qun, S., Pankow, W., Havemann, K., and Schuermann, M. (1998) Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based “enriched PCR” technique. Clin. Cancer Res. 4, 361–371.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Schuermann, M. (2003). Detection of K-ras and p53 Mutations by “Mutant-Enriched” PCR-RFLP. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-324-0:325
Download citation
DOI: https://doi.org/10.1385/1-59259-324-0:325
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-920-9
Online ISBN: 978-1-59259-324-8
eBook Packages: Springer Protocols